⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockGermanyNasdaqGS

BNTX

BioNTech SE

Healthcare · Biotechnology

88.115USD

-1.5550 (-1.73%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on BNTX.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter€0.76▲€0.6630
Next quarter-€0.84▼-€0.8410
Current year-€4.68▼-€4.2612
Next year-€4.81▼-€4.3312

Recent quarters

Beat in 0 of the last 4

QuarterEstimateActualSurprise
2026-06-30-€2.08-€2.22-0.14 (-6.8%)
2026-03-31-€1.92-€1.95-0.03 (-1.6%)
2025-12-31-€0.25-€0.33-0.08 (-30.4%)
2025-09-30€0.1-€0.12-0.22 (-220.3%)

Wall Street coverage

210 ratings from 23 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
Canaccord GenuityMaintainedBuy$136 $132Oct 14, 2026
Morgan StanleyMaintainedOverweight$115 $114Oct 7, 2026
BMO CapitalDowngraded from OutperformMarket Perform$128 $105Sep 8, 2026
Canaccord GenuityMaintainedBuy$142 $136Aug 31, 2026
CitigroupMaintainedBuy$130 $125Aug 5, 2026
Evercore ISI GroupMaintainedOutperform$135 $130Aug 5, 2026
Morgan StanleyMaintainedOverweight$126 $119Jul 8, 2026
UBSUpgraded from NeutralBuy$117 $135May 27, 2026
BernsteinInitiatedMarket Perform$96May 22, 2026
Canaccord GenuityMaintainedBuy$171 $158May 6, 2026
Wells FargoMaintainedOverweight$150 $140May 6, 2026
HC Wainwright & Co.ReiteratedBuy$130Apr 27, 2026
Morgan StanleyMaintainedOverweight$125 $126Apr 10, 2026
HC Wainwright & Co.MaintainedBuy$140 $130Mar 31, 2026
Morgan StanleyMaintainedOverweight$134 $125Mar 11, 2026
Canaccord GenuityMaintainedBuy$171Mar 11, 2026
CitigroupMaintainedBuy$145 $130Mar 11, 2026
TD CowenMaintainedHold$116 $94Mar 11, 2026
BMO CapitalMaintainedOutperform$143 $128Mar 11, 2026
JefferiesMaintainedBuy$151 $138Mar 10, 2026
Goldman SachsUpgraded from NeutralBuy$115 $142Jan 16, 2026
HC Wainwright & Co.MaintainedBuy$136 $140Nov 10, 2025
UBSMaintainedNeutral$115 $117Nov 6, 2025
JP MorganMaintainedNeutral$121 $120Oct 23, 2025
Morgan StanleyMaintainedOverweight$133 $131Oct 10, 2025

Insider transactions

27 filings from 2 insiders · 0 buy / 0 sell over 6m

Officers and directors of BNTX, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell36.2k$95.37$3.45MOct 9, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell27.0k$92.31$2.49MOct 8, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell24.0k$95.86$2.30MOct 7, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell21.0k$96.81$2.03MOct 6, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell72.0k$97.23$7.00MOct 5, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell17.0k$96.72$1.64MOct 2, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell17.0k$97.46$1.66MOct 1, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell32.0k$98.12$3.14MSep 30, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell34.0k$98.26$3.34MSep 29, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell34.0k$98.47$3.35MSep 28, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell27.0k$98.69$2.66MSep 25, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell39.0k$98.99$3.86MSep 24, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell30.0k$99.40$2.98MSep 23, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell46.0k$100.72$4.63MSep 22, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell33.0k$97.81$3.23MSep 21, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell30.0k$96.22$2.89MSep 18, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell34.0k$98.60$3.35MSep 17, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell15.0k$96.09$1.44MSep 16, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell34.0k$96.49$3.28MSep 15, 2026
Sahin UgurOfficer, Chief Executive Officer; 10% ownerSell41.0k$99.45$4.08MSep 14, 2026

Analyst Notes

Sign in to write

No analyst notes on BNTX yet.

Analyst Ratings

20 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current113700Buy2.29
1 mo ago113501Buy2.35
2 mo ago114401Buy2.30
3 mo ago114500Buy2.20
Price target$116.70$76.04 – $144.08
+32.4% to target

Top voices on BNTX

Members whose judged calls on BNTX have played out most reliably.

No settled calls on BNTX yet. Nobody has filed a call with a deadline on it.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice